edaravone
UkraineDrugs containing this active substance
-
The drug is used to alleviate neurological symptoms and functional impairments following an acute ischemic stroke, as well as to slow the progression of functional disorders in amyotrophic lateral sclerosis (ALS).
Form: solution for injection
Active substance Dosage edaravone 1.5 mg/ml ATC: N07XX14
Manufacturer: Farmak JSC
-
The drug is used for the treatment of amyotrophic lateral sclerosis (ALS).
Form: solution for infusion
Active substance Dosage edaravone 0.3 mg/ml ATC: N07XX14
Manufacturer: Farmak JSC
-
The drug is used to alleviate neurological symptoms and functional disorders in acute ischemic stroke, to slow the progression of amyotrophic lateral sclerosis (ALS), and as part of complex treatment for the systemic inflammatory response in coronavirus disease (COVID-19).
Form: solution for injection
Active substance Dosage edaravone 1.5 mg/ml ATC: N07XX14
Manufacturer: Yuria-Pharm LLC